United States · FDA National Drug Code directory
Lamzede
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10122-180_27cf090b-196e-4330-8184-c72d9bb90660
- Product NDC
- 10122-180
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Velmanase alfa-tycv
- Labeler
- Chiesi USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230301
- Source listing expiry
- 20261231
Source-listed ingredients
- VELMANASE ALFA-TYCV — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-02) · 10122-180-02
- 5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-05) · 10122-180-05
- 10 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-10) · 10122-180-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →